Artemis Hospitals
| Índia | Turquia | Áustria | |
| Transplante de medula óssea | de $15,000 | de $36,000 | de $140,000 |
| Transplante alogénico de medula óssea de dador relacionado | de $20,500 | de $65,000 | de $150,000 |
| Transplante alogénico de medula óssea de dador não relacionado | de $28,000 | de $80,000 | de $180,000 |
| Terapia com células T CAR | de $50,000 | de $150,000 | de $350,000 |
| Terapia biológica | de $1,800 | de $5,500 | de $20,000 |
A Bookimed não adiciona taxas extras aos preços de tratamento de Oncologia Hematológica. As tarifas vêm das listas oficiais das clínicas. O pagamento é feito diretamente na clínica na chegada ao país.
A Bookimed está comprometida com sua segurança. Trabalha apenas com instituições que mantêm altos padrões internacionais no tratamento de Oncologia Hematológica e têm as licenças necessárias para atender pacientes internacionais em todo o mundo.
A Bookimed oferece assistência gratuita de especialistas. Um coordenador médico pessoal apoia antes, durante e após o tratamento, solucionando problemas. Nunca está sozinho em sua jornada de tratamento de Oncologia Hematológica.
O Dr. Kalashetty é especialista em transplante de medula óssea – um procedimento fundamental para o tratamento de distúrbios sanguíneos complexos nos Hospitais Manipal.
Specific diagnosis and staging require clinical evaluation of biopsy results, blood work, and imaging scans. Hematologists in India use bone marrow biopsies and flow cytometry to identify subtypes. They categorize leukemia by cell type and lymphoma by node involvement using numerical stages I–IV.
Bookimed Expert Insight: Indian centers like Global Hospital Chennai and BLK Super Speciality Hospital operate high-volume transplant programs. These facilities often provide faster access to specialized tests like flow cytometry than public institutions. This speed is critical for acute cases where treatment must start within days of the first symptom.
Patient Consensus: Many patients find the initial `blood cancer` label vague and stressful. They suggest getting a second opinion at private centers to confirm the exact genetic markers and staging quickly.
A bone marrow biopsy and genetic testing are standard requirements in India before starting treatment for blood cancers. These tests confirm your specific diagnosis and identify chromosomal abnormalities. This data allows specialists to choose the most effective targeted therapies or intensive chemotherapy protocols for your condition.
Bookimed Expert Insight: Indian centers like Global Hospital Chennai and BLK Super Speciality Hospital often provide faster diagnostic turnarounds than public facilities. While public hospitals may take 4 weeks for biopsy reports, private labs in these JCI-accredited hubs typically deliver results much quicker. This speed is vital for starting induction therapy without life-threatening delays.
Patient Consensus: Patients note that while these procedures are uncomfortable, they are essential for getting the right medication. Many suggest using private labs to avoid long wait times for critical genetic reports.
Primary hematology-oncology treatments in India include bone marrow transplant (BMT), targeted therapies, and intensive chemotherapy protocols. Major centers in Delhi, Bengaluru, and Gurgaon offer allogeneic and autologous stem cell transplantation. These facilities treat complex leukemias, lymphomas, and multiple myeloma using JCI-accredited standards.
Bookimed Expert Insight: India's hematology landscape shows a unique trend where high-volume centers like Manipal Hospitals serve 2,000,000 patients annually. This massive scale allows surgeons like Dr. Rahul Bhargava to complete 1,000+ transplants. High patient turnover often leads to lower costs and more refined post-operative protocol management compared to smaller regional clinics.
Patient Consensus: Patients emphasize the importance of getting a second opinion at a major metro hospital before starting treatment. They note that while local chemotherapy is accessible, traveling to cities like Delhi or Bengaluru is essential for successful stem cell transplants.
Hematology oncology patients in India most commonly experience fatigue, nausea, and low blood counts during treatment. Fever and infections from neutropenia are frequent. Hair loss and digestive issues like diarrhea occur often. Nerve numbness or mouth sores may also develop during chemotherapy or bone marrow transplants.
Bookimed Expert Insight: Data from major Indian hubs like Delhi and Gurgaon shows a high volume of complex transplants. Dr. Dharma Choudhary at BLK Super Speciality Hospital has led over 850 allogeneic transplants. This high volume means nursing teams are exceptionally skilled at spotting early signs of graft-versus-host disease. Patients should prioritize clinics with dedicated BMT floors to minimize cross-infection risks during recovery.
Patient Consensus: Many patients find that keeping a stock of electrolyte drinks helps manage the intense dehydration from nausea. Avoiding spicy foods and using simple aloe vera gel for scalp irritation are practical steps that make daily recovery much easier.
India provides CAR-T cell therapy for blood cancers since late 2023. Approved treatments include NexCAR19 and Qartemi for B-cell lymphomas and leukemia. These indigenous therapies offer high efficacy for refractory cases. Specialized hematology centers in Delhi and Mumbai deliver these advanced cellular treatments.
Bookimed Expert Insight: Patient volume significantly impacts care quality in India. Clinics like Apollo Hospital Indraprastha and Manipal Hospitals serve over 1,000,000 patients annually. This massive scale allows these institutions to maintain specialized cells for managing intensive side effects like cytokine release syndrome. Choosing a high-capacity facility often means better access to 24/7 intensive care support.
Patient Consensus: Patients note that while treatment is available, preparing for a 2–4 week hospital stay is essential. Many emphasize using crowdfunding platforms or government subsidies to help manage the total medical expenses.
Patients typically stay in India for 2 to 4 weeks during initial hematology oncology treatment phases. Complex procedures like bone marrow transplants require a minimum of 4 to 8 weeks. This timeframe covers pre-conditioning, the transplant itself, and essential initial recovery monitoring to ensure medical stability.
Bookimed Expert Insight: Data from high-volume centers like Apollo Hospital Indraprastha and Global Hospital Chennai shows a shift toward hybrid recovery models. Patients often move to specialized recovery hotels after 3 to 7 days of hospitalization. This strategy significantly reduces total costs while maintaining proximity to medical teams for vital monitoring.
Patient Consensus: Patients note that staying in serviced apartments after the first week makes the long recovery much more comfortable. They also suggest securing a medical visa early since treatment timelines can extend if clinical counts take longer to stabilize.
Patients in India can often maintain light daily activities during hematology oncology treatment. Success depends on tracking energy patterns, as capacity typically drops by 30–50%. Most clinical protocols at JCI-accredited centers like Artemis Hospitals or BLK Super Speciality Hospital encourage movement to manage fatigue and mood.
Bookimed Expert Insight: Data from major Indian hubs like Gurgaon and Delhi shows that clinics with high transplant volumes, such as Fortis Gurgaon or Medanta, emphasize a 48-hour post-treatment buffer. Scheduling vital activities for the second week of a cycle often yields the best results. This allows patients to recover during the most intense side-effect window immediately following therapy.
Patient Consensus: Energy levels are unpredictable, so it is better to listen to your body than a calendar. Many patients suggest delegating household chores early to avoid the physical and emotional strain of pushing through exhaustion.